Zeo Scientifix (ZEOX) major holder reports 43.02% aggregate voting control

Rhea-AI Filing Summary

Zeo Scientifix, Inc. investor Wendy Grey, through Greyt Ventures, LLC, filed Amendment No. 1 to a Schedule 13D updating her ownership and voting power. She now beneficially owns 1,405,000 shares of common stock, including 1,155,000 shares issuable upon exercise of warrants.

Based on 7,614,941 common shares outstanding as of January 28, 2026, this represents 17.52% of the common stock voting power. Grey also holds 50 shares of Series C Preferred Stock that provide an additional 25.5% of total voting power, giving her aggregate voting power of 43.02%. The added position reflects warrant grants under Zeo Scientifix’s 2021 Equity Incentive Plan in July 2024 and May 2025, and she currently has sole voting and dispositive power over all reported shares while stating no definite plans for major corporate changes.

Insights

Equity ownership and governance analyst

Major Zeo Scientifix holder reports 43.02% aggregate voting power.

Wendy Grey, via Greyt Ventures, LLC, reports beneficial ownership of 1,405,000 Zeo Scientifix common shares, including 1,155,000 issuable from warrants. On 7,614,941 common shares outstanding as of January 28, 2026, this equals 17.52% of the common stock voting power.

She also holds 50 shares of Series C Preferred Stock providing an additional 25.5% of total voting power, bringing aggregate voting power to 43.02%. Recent increases stem from warrant grants for 350,000 and 55,000 shares under the 2021 Equity Incentive Plan on July 11, 2024 and May 16, 2025, respectively.

The filing states she has sole voting and dispositive power over these securities and currently has no definite plans for acquisitions, sales, or corporate transactions beyond potential future equity awards. Future company filings may clarify any changes in her ownership or intentions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)

Zeo Scientifix, Inc.

(Name of Issuer)

Shares of Common Stock $0.001 Par Value and Series C Preferred Stock $.001 Par Value

(Title of Class of Securities)

68621D206

(CUSIP Number)

Ian T. Bothwell
3321 COLLEGE AVENUE, SUITE 246
DAVIE, FL, 33314
888-963-7881

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

01/14/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 68621D206

1

Name of reporting person

Grey Wendy

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,405,000.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,405,000.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

1,405,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

17.52 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

The number of shares Beneficially Owned by the Reporting Person consists of 1,405,000 shares of common stock of the Issuer (including 1,155,000 shares of common stock of the Issuer issuable upon exercise of warrants held by the Reporting Person) representing 17.52% of the voting power based on 7,614,941 shares of common stock outstanding as of January 28, 2026, as reported by the Issuer in its 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission on January 29, 2026 and giving effect to the exercise of the warrants held by the Reporting Person. In addition, the Reporting Person holds 50 shares of Series C Preferred Stock which provides the Reporting Person with an additional 25.5% of the total voting power. Accordingly, the Reporting Person's aggregate voting power is equal to 43.02%.

SCHEDULE 13D

CUSIP No. 68621D206

1

Name of reporting person

Greyt Ventures, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,405,000.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,405,000.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

1,405,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

17.52 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

The number of shares Beneficially Owned by the Reporting Person consists of 1,405,000 shares of common stock of the Issuer (including 1,155,000 shares of common stock of the Issuer issuable upon exercise of warrants held by the Reporting Person) representing 17.52% of the voting power based on 7,614,941 shares of common stock outstanding as of January 28, 2026, as reported by the Issuer in its 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission on January 29, 2026 and giving effect to the exercise of the warrants held by the Reporting Person. In addition, the Reporting Person holds 50 shares of Series C Preferred Stock which provides the Reporting Person with an additional 25.5% of the total voting power. Accordingly, the Reporting Person's aggregate voting power is equal to 43.02%.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Shares of Common Stock $0.001 Par Value and Series C Preferred Stock $.001 Par Value
(b)	Name of Issuer: Zeo Scientifix, Inc.
(c)	Address of Issuer's Principal Executive Offices: 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FLORIDA , 33314.
Item 1 Comment: This Amendment No. 1 to the Statement on Schedule 13D ("Amendment No. 1") filed with the Securities and Exchange Commission (the "SEC") on September 16, 2022 (the "Schedule 13D"), on behalf of Wendy Grey and Greyt Ventures, LLC (the "Reporting Persons"), with respect to the common stock of Zeo ScientifiX, Inc. (the "Issuer"), is being filed pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to amend and supplement certain information set forth below in the items indicated. All capitalized terms used in this Amendment No. 1 and not otherwise defined herein have the meanings ascribed to such terms in the Schedule 13D filed with the SEC on September 16, 2022. Except as amended and supplemented herein, the Schedule 13D, including the definitions of capitalized terms not otherwise defined herein, remains in full force and effect.
Item 2.	Identity and Background
(a)	This Amendment No. 1 is being filed by the Reporting Person;
(b)	The Reporting Person's business address is 20533 Biscayne Boulevard, Suite 648, Aventura, Florida 33180;
(c)	Not applicable;
(d)	The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors);
(e)	The Reporting Person was not, during the last five years, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws; and
(f)	Not applicable.
Item 3.	Source and Amount of Funds or Other Consideration
	The additional shares of the Issuer's common stock held by the Reporting Person as reported in Item 5(c) of and elsewhere in this Amendment No. 1 represent (i) warrants to purchase 350,000 shares of common stock issued to the Reporting Person on July 11, 2024 under the Issuer's 2021 Equity Incentive Plan (the "Plan"); and (ii) warrants to purchase 55,000 shares of common stock issued to the Reporting Person on May 16, 2025 under the Plan.
Item 4.	Purpose of Transaction
	The additional shares of the Issuer's common stock acquired by the Reporting Person as reported in Item 5(c) of and elsewhere in this Amendment No. 1, were issued to the Reporting Person as described in Item 3, above. The Reporting Person has no definite plan to acquire or dispose of additional shares of the Issuer's common stock in open market or private transactions, but may do so in the future, subject to compliance with the Exchange Act and the rules and regulations thereunder. In addition, while there is no definite plan to issue additional shares of the Issuer's common stock to the Reporting Person under one or more of the Issuer's equity incentive plans, the board of directors or a committee thereof may determine to issue awards of shares of common stock under such plans to the Reporting Person from time to time in the future. Except as set forth in the preceding paragraph, the Reporting Person has no plans or proposals which relate to or would result in: (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (b) Any additional extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the issuer; (f) Any other material change in the issuer's business or corporate structure including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above.
Item 5.	Interest in Securities of the Issuer
(a)	As of the filing date of this Amendment No. 1, the Reporting Person beneficially owns 1,405,000 shares of the common stock of the Issuer (including 1,155,000 shares of common stock of the Issuer issuable upon exercise of warrants held by the Reporting Person), representing 17.52% of the class after giving effect to the exercise of warrants held by the Reporting Person (the Reporting Person also holds 50 shares of Series C Preferred Stock which provides the Reporting Person with an additional 25.5% of the total voting power of the Issuer);
(b)	The Reporting Person has sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of all of the 1,405,000 shares; and
(c)	The Reporting Person has effected the following transactions in the class of securities reported on (the Issuer's common stock) since the most recent Schedule 13D filing: Date Nature of Transaction Number of Shares Price 7/11/2024 Grant of Warrants under the Issuer's 2021 Incentive Plan 350,000 $0.00 5/16/2025 Grant of Warrants under the Issuer's 2021 Incentive Plan 55,000 $0.00
(d)	None.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	There are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer.
Item 7.	Material to be Filed as Exhibits.
	None.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Grey Wendy

Signature:	/s/ Wendy Grey
Name/Title:	Wendy Grey
Date:	02/06/2026

Greyt Ventures, LLC

Signature:	/s/ Wendy Grey
Name/Title:	Wendy Grey, Manager
Date:	02/06/2026

Comments accompanying signature:

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

FAQ

How many Zeo Scientifix (ZEOX) shares does Wendy Grey beneficially own?

Wendy Grey beneficially owns 1,405,000 Zeo Scientifix common shares, including 1,155,000 issuable upon warrant exercise. This total is calculated against 7,614,941 common shares outstanding as of January 28, 2026, as disclosed in the company’s 2025 Annual Report.

What percentage of Zeo Scientifix (ZEOX) common stock voting power does Wendy Grey hold?

Wendy Grey’s 1,405,000 common shares represent 17.52% of Zeo Scientifix’s common stock voting power. This percentage is based on 7,614,941 shares outstanding as of January 28, 2026, and includes shares issuable upon exercise of her warrants.

How does Wendy Grey reach 43.02% total voting power in Zeo Scientifix (ZEOX)?

Wendy Grey holds 17.52% voting power through common stock and warrants plus 50 Series C Preferred shares that provide an additional 25.5% of total voting power. Combined, these positions give her aggregate voting power of 43.02% in Zeo Scientifix.

What new securities did Wendy Grey receive from Zeo Scientifix (ZEOX) under the 2021 plan?

She received warrants for 350,000 common shares on July 11, 2024, and warrants for 55,000 common shares on May 16, 2025. Both grants were issued under Zeo Scientifix’s 2021 Equity Incentive Plan at a stated price of $0.00 per warrant grant.

Does Wendy Grey have plans to change control or strategy at Zeo Scientifix (ZEOX)?

The filing states Wendy Grey has no current plans or proposals for mergers, major asset sales, board changes, or other significant corporate actions. She notes only that future open-market or plan-related transactions may occur in compliance with applicable securities laws.

What powers does Wendy Grey have over her Zeo Scientifix (ZEOX) holdings?

The filing reports that Wendy Grey has sole voting and sole dispositive power over all 1,405,000 common shares she beneficially owns. This means she alone can decide how these shares are voted and whether, when, and how they are sold or transferred.